84 results
8-K
EX-99.1
BRSF
Brain Scientific Inc.
2 Nov 22
Daniel Cloutier, a Veteran Sales Executive, Joins Brain Scientific as Chief Revenue Officer
5:56pm
; lack of product diversification; volatility in the price of the company's raw materials; and the failure to implement the company's business plans
D
f1lrk5
19 Jul 22
$5.15M in debt / options, sold $5.15M, 11 investors
12:59pm
DEF 14C
617l g30yr9vt
5 Jul 22
Information statement
11:02am
PRE 14C
3p0 7on8guxf3nw
24 Jun 22
Preliminary information
12:36pm
8-K
EX-10.1
wmdw8n qln856
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-99.1
0drd7v dah4
15 Jun 22
Entry into a Material Definitive Agreement
11:15am
8-K
EX-99.1
63husgrpxbll0e
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
zc8rw21j 17r
19 Apr 22
Regulation FD Disclosure
3:18pm
8-K
EX-10.1
7ypo1lgl fu
16 Feb 22
Entry into a Material Definitive Agreement
4:01pm
8-K
q6vtk7u
13 Jan 22
Regulation FD Disclosure
5:28pm
8-K
EX-99.1
3rsrc
13 Jan 22
Regulation FD Disclosure
5:28pm
D
spu61r543
13 Jan 22
$20M in debt / options, sold $9.66M, 13 investors
4:33pm
8-K
EX-10.1
j111765ycjayhz t4fs
28 Dec 21
Entry into a Material Definitive Agreement
4:18pm
8-K/A
EX-99.2
wiw27s6tsb
15 Dec 21
Audited Consolidated Financial Statements
10:49am